RxDoctor Payments Data

Hend Andrew, MD

Family Medicine · New Port Richey, FLNPI 1366456881

Payments from drug & device makers

$5,672in general payments, 2019–2025

Across 332 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$746
  • Novo Nordisk$733
  • Pfizer$452
  • GSK$437
  • Amgen$417
  • Lilly USA, LLC$409
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$5,672100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,672 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$59,873
Medicare patients
153
Services billed
509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol46$41,846
JardianceEmpagliflozin24$38,186
MounjaroTirzepatide32$36,208
EliquisApixaban28$34,901
OzempicSemaglutide29$34,585
JanuviaSitagliptin Phosphate35$31,814
XareltoRivaroxaban13$22,391
MyrbetriqMirabegron18$19,537
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$7,963
SynthroidLevothyroxine Sodium34$3,929
BreynaBudesonide/Formoterol Fumarate15$3,183
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$2,427
Rosuvastatin Calcium170$2,402
Levothyroxine Sodium169$1,953
Atorvastatin Calcium207$1,633

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$746$41,84646 claims
Boehringer IngelheimJardiance$308$38,18624 claims
Lilly USA, LLCMounjaro$409$36,20832 claims
PfizerEliquis$452$34,90128 claims
Novo NordiskOzempic$733$34,58529 claims
MerckJanuvia$80$31,81435 claims
Johnson & JohnsonXarelto$187$22,39113 claims
Astellas Pharma US IncMyrbetriq$32$19,53718 claims
GSKAnoro Ellipta$437$7,96313 claims
AbbVieSynthroid$159$3,92934 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.

Other family medicine in New Port Richey

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →